95835-64-6

Usage

Uses

Used in Pharmaceutical Industry:
4-CHLORO-6-METHYL-3-NITROPYRIDIN-2(1H)-ONE is used as an intermediate in the synthesis of various pharmaceuticals for its potential biological and pharmacological activities.
Used in Agrochemical Industry:
4-CHLORO-6-METHYL-3-NITROPYRIDIN-2(1H)-ONE is used as an intermediate in the synthesis of agrochemicals, contributing to the development of effective pesticides and other agricultural products.
Used in Organic Compounds Synthesis:
4-CHLORO-6-METHYL-3-NITROPYRIDIN-2(1H)-ONE is used as an intermediate in the synthesis of various organic compounds, facilitating the creation of new chemical entities with potential applications in different industries.
Safety Precautions:

Upstream product

• 4966-90-9 4-hydroxy-6-methyl-3-nitro-2(1H)-pyridinone 
• 108-91-8 cyclohexylamine 
• 4966-90-9 2,4-Dihydroxy-6-methyl-3-nitropyridine 
• 10025-87-3 trichlorophosphate 

Downstream Products

• 606489-96-7 6-methyl-1,5-dihydro-imidazo[4,5-c]pyridin-4-one 
• 219736-00-2 4Benzylamino-6-methyl-3-nitro-pyridin-2-ol 
• 1036209-25-2 C₁₆H₂₁ClN₂O₅ 
• 1228150-25-1 C₁₄H₁₄N₂O₄S 
• 1228150-26-2 C₁₄H₁₃ClN₂O₃S 
• 63897-15-4 4-amino-6-methyl-3-nitro-pyridin-2-ol 
• 52334-79-9 2-hydroxy-6-methyl-3-aminopyridine 
• 858514-60-0 [[4-(butyl-ethyl-amino)-6-methyl-3-nitro-pyridin-2-yl]-(2,6-dichloro-4-cyano-phenyl)-amino]-acetic acid ethyl ester 
• 856686-06-1 ((2-bromo-4-isopropyl-phenyl)-{4-[ethyl-(3-methanesulfonyl-propyl)-amino]-6-methyl-3-nitro-pyridin-2-yl}-amino)-acetic acid ethyl ester 
• 856684-13-4 {(2-chloro-4-cyano-phenyl)-[4-(cyclobutylmethyl-propyl-amino)-6-methyl-3-nitro-pyridin-2-yl]-amino}-acetic acid ethyl ester 

Relevant academic research and scientific papers

Syntheses of 4- and 6-substituted thiazolo[4,5-c]pyridines

A general synthetic approach to 4,6-substituted thiazole[4,5-c]pyridines, involving a novel one-pot thiol deprotection-cyclization key step, is described.

Synthesis, structure-activity relationships, and in vivo properties of 3,4-dihydro-1H-pyrido[2,3-b]pyrazin-2-ones as corticotropin-releasing factor-1 receptor antagonists

Corticotropin releasing factor (CRF) is the primary regulator of the hypothalamus-pituitary-adrenal (HPA) axis, coordinating the endocrine, behavioral, and autonomic responses to stress. It has been postulated that small molecules that can antagonize the

Certain alkylene diamine-substituted heterocycles

The present invention also provides a general method to whereby mono-, bi-, or tricyclic heterocycles may be modified to obtain potent antagonists at the NPY1receptor. The present invention provides novel, potent, non-peptidic antagonists of NP

Arylamino fused pyrimidines

Corticotropin releasing factor (CRF) antagonists of formula I or formula II: and their use in treating anxiety, depression, and other psychiatric and neurological disorders.

1N-alkyl-N-arylpyrimidinamines and derivatives thereof

The present invention provides novel compounds, compounds and pharmaceutical compositions thereof, and methods of using same in the treatment of affective disorders, anxiety, depression, post-traumatic stress disorders, eating disorders, supranuclear palsy, irritable bowel syndrome, immune suppression, Alzheimer's disease, gastrointestinal diseases, anorexia nervosa, drug and alcohol withdrawal symptoms, drug addiction, inflammatory disorders, or fertility problems. The novel compounds provided by this invention are those of formula: wherein R1, R3, R4, R5, Z, Y, V, X, X', J, K, L, and M are as defined herein.

Thrombin inhibitors

A compound which inhibits human thrombin and where has the structure